Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mesothelioma × Vorinostat × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Lymphoma 16 Leukemia, Myeloid, Acute 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Breast Neoplasms 14 Multiple Myeloma 12 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma, Non-Hodgkin 10 Carcinoma, Non-Small-Cell Lung 10 Leukemia 9 Hodgkin Disease 9 Myelodysplastic Syndromes 8 Lymphoma, Mantle-Cell 8 Lymphoma, Follicular 8 Neuroblastoma 7 Neoplasm Metastasis 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Brain Neoplasms 7 Recurrence 6 Neoplasms, Plasma Cell 6 Lymphoma, B-Cell, Marginal Zone 6 Lung Neoplasms 6 Pancreatic Neoplasms 5 Lymphoma, T-Cell, Cutaneous 5 Lymphoma, Large-Cell, Anaplastic 5 Immunoblastic Lymphadenopathy 5 Glioblastoma 5 Burkitt Lymphoma 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

Pemetrexed 20 Cisplatin 17 Nivolumab 7 Gemcitabine 7 Carboplatin 7 durvalumab 5 Radiotherapy, Intensity-Modulated 4 Ipilimumab 4 Bevacizumab 4 tremelimumab 3 pembrolizumab 3 niraparib 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 Thoracoscopy 2 Surveys and Questionnaires 2 Sorafenib 2 Radiosurgery 2 Oxaliplatin 2 Magnesium Sulfate 2 Leucovorin 2 Imatinib Mesylate 2 Drug Therapy 2 Doxorubicin 2 Dexamethasone 2 Cyclophosphamide 2 sodium thiosulfate 1 pevonedistat 1 perflutren 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01353482 2012-03-22

MESO-02

University College, London

Phase 1/2 Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡